PTEN and p53 Gene Expressions in Breast Cancer Specimens and their Clinicopathological Significance

Journal Title: Middle East Journal of Cancer - Year 2018, Vol 9, Issue 2

Abstract

Background: Breast cancer is the second leading cause of cancer death after lung cancer. Discovering molecular biomarkers is necessary for disease management that includes prognosis prediction and preventive treatment. The aim of this study is to evaluate the expression value of p53 and PTEN as molecular biomarkers of breast cancer and their relation with clinicopathological characteristics. Methods: In this study, 100 breast cancer and 20 normal samples were subjected to investigation. Total RNA was isolated and we measured RNA expression by realtime RT-PCR. Data were analyzed by REST 2009 and SPSS. Results: Gene expression results showed up-regulation of P53 in 53 breast cancer subjects and PTEN in 52 breast cancer subjects compared with normal controls. However, there was lower P53 expression in 25 breast cancer samples compared to normal tissues. PTEN expression was lower in 26 breast cancer samples than normal tissues. p53 showed a significant relationship to HER2 receptor (P=0.024) and menopausal status (P=0.013); no significant relationships existed with other clinicopathological parameters (P>0.05). PTEN had the only significant correlation with lymphatic invasion (P=0.046) without any relation with other clinicopathological features (P>0.05). PTEN expression had no significant association with p53 expression in the studied population (P=0.074). Conclusion: Combined detection of PTEN and p53 may have the potential to estimate the pathobiological behavior and prognosis of breast cancer. Due to the heterogeneous nature of cancer and the presence of different factors involved in the clinical situation of breast cancer, we suggest a study of a larger population and more biomarkers.

Authors and Affiliations

Hamzeh Salmani, Arshad Hosseini, Asaad Azarnezhad, Hussain Ahmad

Keywords

Related Articles

Endocan, ET-1, and ETAR Expression Profiles in Unicystic Ameloblastoma, Multicystic Ameloblastoma, and Ameloblastic Carcinoma

Background: Odontogenic lesions range from simple cysts to benign tumors and carcinomas. Unicystic ameloblastoma is a monocystic lesion and a less aggressive tumor compared to multicystic ameloblastoma. Ameloblastic carc...

MRI of Breast Lymphoma: A Report of Two Cases with Emphasis on Diffusion Weighted Imaging and Apparent Diffusion Coefficient Value

Breast lymphoma is a rare neoplasm that accounts for approximately 0.04-0.5% of breast malignancies. Most breast lymphomas are B-cell type non-Hodgkin lymphomas. The imaging features of breast lymphoma on mammography and...

Assessment of Elevated Serum Tumor Markers Carcinoembryonic Antigen (CEA) and Cancer Antigen 15-3 (CA15-3) among Patients with Different Subtypes of Metastatic Breast Cancer

Background: Cancer antigen 15-3 and carcinoembryonic antigen are used in clinical and laboratory diagnosis of metastatic breast cancer. Previous studies have noted conflicting results about the association between carcin...

Evaluation of Promoter Hypermethylation of Tumor-Suppressor Genes p14 and p16 in Iranian Endometrial Carcinoma Patients

Background: Endometrial cancer is a common gynecological malignancy with good prognosis in the early stages of the disease. The CpG island in the promoter region of tumor-suppressor genes are frequently methylated in var...

Download PDF file
  • EP ID EP303034
  • DOI -
  • Views 79
  • Downloads 0

How To Cite

Hamzeh Salmani, Arshad Hosseini, Asaad Azarnezhad, Hussain Ahmad (2018). PTEN and p53 Gene Expressions in Breast Cancer Specimens and their Clinicopathological Significance. Middle East Journal of Cancer, 9(2), 105-111. https://europub.co.uk/articles/-A-303034